A call to action: Health-system pharmacists must stand up to meet the growing demand for cellular-based therapies

Affiliations

¹ Department of Pharmacy, Nationwide Children's Hospital, Columbus, OH, USA.
² Investigational Drug Services, UNC Health, Chapel Hill, NC, and Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
³ Department of Pharmacy, University of California San Diego, La Jolla, CA, USA.
⁴ Department of Pharmacy, Investigational Drug Service, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
⁵ Pharmacy Department, Investigational Drug Service, Seattle Children's Hospital, Seattle, WA, USA.

Jill E Blind et al. Am J Health Syst Pharm. 2023.

. 2023 Jul 7;80(14):944-947.

doi: 10.1093/ajhp/zxad071.

¹ Department of Pharmacy, Nationwide Children's Hospital, Columbus, OH, USA.
² Investigational Drug Services, UNC Health, Chapel Hill, NC, and Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
³ Department of Pharmacy, University of California San Diego, La Jolla, CA, USA.
⁴ Department of Pharmacy, Investigational Drug Service, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
⁵ Pharmacy Department, Investigational Drug Service, Seattle Children's Hospital, Seattle, WA, USA.

No abstract available

Keywords: CAR T cell therapy; advanced therapy medicinal product; biologic; cellular therapy; gene therapy.

LinkOut - more resources